3-Bracket Pricing Rule for Generics Should Be Defended: Sawai Chairman

Sawai Pharmaceutical Chairman Hiroyuki Sawai Hiroyuki Sawai, chairman of Japanese generic major Sawai Pharmaceutical, on March 24 urged the government to at least stick to the current three-bracket price-grouping rule for generic drugs in the upcoming NHI pricing reform in...read more